<DOC>
	<DOCNO>NCT02881918</DOCNO>
	<brief_summary>The purpose description anti-tumor immune responses general accord clinical stage disease free survival ( DFS : survival without recurrence ( local distant ) ) patient Head &amp; Neck Squamous Cell Carcinoma Secondary purpose : - Study relationship anti-tumor immune response qualitative ( yes/no ) quantitative ( number ) presence circulate tumor cell ( CTCs ) ; - Study relationship qualitative ( yes/no ) quantitative ( number ) presence CTCs clinical stage well DFS - Study relationship anti-tumor immune response clinical stage well DFS .</brief_summary>
	<brief_title>Anti-tumor Specific Immune Response Head Neck Cancers</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>Patient Head &amp; Neck Squamous Cell Carcinoma extension assessment , regardless clinical stage ( TNM UICC stage IIV ) , medical surgical treatment specifically direct cancer ( radiotherapy , surgery , chemotherapy target therapy ) Consent participate study , nonopposition Affiliation social security History neoplasia , synchronous cancer , autoimmune disease , organ transplantation , chemotherapy HIV infection Corticotherapy 15 day blood sampling</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>